contribute to the answer. Applying time and energy to answer the important questions will always be more effective and satisfying.
As we crowd into the main arena of the America College of Cardiology Scientific Sessions, the American Heart Association Scientific Sessions, the Transcatheter Cardiovascular Therapeutics Annual Meeting, or the European Society of Cardiology or EuroPCR meeting to hear the late-breaking trial results, or as we digest the published reports, we should be thankful to those patients and physicians who have made the findings possible. But we should also be concerned that we have not done enough to ensure timely completion of other clinical trials that will influence effective and efficient care. As "inconvenient" as it may sometimes be, helping our patients discharge their duty to participate in the trials that will lead to benefit for all is our duty as well.
